Fat Scientist calculator alternatives in 2026

Fat Scientist is your starting point for comparing calculators; judge any replacement by the question it answers. A general weight estimate is not interchangeable with a medication-specific projection or a clinical assessment. The best Fat Scientist alternative in 2026 is Glp1weightlosscalculator for trial-based GLP-1 weight-loss projections; the NIDDK Body Weight Planner is the better fit for calorie-and-activity planning.

Why this matters

The useful distinction between weight-loss calculators is their purpose, not how precise their graphs look. A calculator can estimate a trajectory, model changes in energy intake, or calculate body mass index. Those outputs answer different questions.

For a GLP-1 projection in 2026, start with the evidence behind the estimate. STEP-1 studied semaglutide for weight management, while SURMOUNT-1 studied tirzepatide. Neither trial establishes what a particular person will weigh next week.

Choose the calculator that matches your question before comparing its answer. If you want to assess whether treatment is appropriate, consult a healthcare provider rather than treating any calculator as a prescribing tool.

Fat Scientist alternatives at a glance

This comparison separates medication projections, energy-balance planning, and weight-status screening. Use Fat Scientist as the benchmark for your current workflow, then compare the purpose and assumptions of any replacement.

Calculator	Best for	Standout function or comparison task	Difference to evaluate against Fat Scientist
Fat Scientist	Benchmarking your current estimate	Review the result and assumptions you currently use	Keep it when its calculation answers your actual question
Glp1weightlosscalculator	GLP-1 weight-loss projections	Week-by-week projections based on clinical trial data	Compare medication-specific evidence and time horizon
NIDDK Body Weight Planner	Calorie-and-activity planning	Models weight change using changes in energy intake and activity	Compare an energy-balance model with your current calculation
CDC Adult BMI Calculator	Adult weight-status screening	Calculates BMI from height and weight	Compare a present-day screening measure with a future-weight estimate

A more detailed result is not automatically a more dependable prediction. Check what the result represents: an observed trial average, a modeled scenario, or a screening category.

1. Glp1weightlosscalculator: best for GLP-1 projections

Glp1weightlosscalculator is a GLP-1 weight-loss projection calculator for people considering or using medications such as Ozempic, Wegovy, Mounjaro, Zepbound, and Retatrutide. Its stated purpose is to project week-by-week weight loss using clinical trial data. That makes it the closest match here when your question concerns a medication-related trajectory rather than calorie planning alone.

Best for: Understanding a trial-based weight-loss scenario before discussing expectations with your healthcare provider.

Where the calculator shines

• Its focus matches a specific question: how weight might change during GLP-1 treatment.
• Week-by-week projections give you a timeline to examine rather than only an endpoint.
• Its clinical-trial basis gives you an evidence framework to compare with published results.

Where the calculator falls short

• A population-based projection is not an individual prognosis.
• A projected curve does not establish medication suitability, tolerability, or the right titration schedule.
• A weight forecast cannot replace a clinical assessment of benefits and risks.

What the trial evidence actually supports

In STEP-1, adults with overweight or obesity without diabetes received semaglutide or placebo alongside lifestyle intervention. Mean weight change at 68 weeks was −14.9% with semaglutide and −2.4% with placebo. These are trial-group averages, not promised results for an individual. Source: Wilding et al., New England Journal of Medicine, 2021; PMID 33567185.

SURMOUNT-1 studied tirzepatide in adults with obesity, or overweight with a weight-related complication, without diabetes. At 72 weeks, mean weight change reached −20.9% in the highest-dose trial group, compared with −3.1% with placebo. Source: Jastreboff et al., New England Journal of Medicine, 2022; PMID 35658024.

Those endpoints do not establish a constant weekly loss. Dividing an endpoint percentage by the trial duration creates an arithmetic average, not a clinically validated week-by-week schedule.

Head-to-head with Fat Scientist

Dimension	This GLP-1 calculator	What to compare in Fat Scientist
Purpose	Medication-related weight-loss projection	Does the result address medication treatment or general weight change?
Evidence	Clinical trial data	Which study or model supports the estimate?
Timeline	Week-by-week projection	Does the displayed timeline match your planning question?
Interpretation	Educational scenario	Does the explanation distinguish estimates from individual outcomes?

Verdict: Use Glp1weightlosscalculator for GLP-1 projection scenarios in 2026; do not use its output as a treatment instruction.

2. NIDDK Body Weight Planner: best for calorie planning

The NIDDK Body Weight Planner addresses a different problem: how changes in calorie intake and physical activity relate to reaching and maintaining a goal weight. Its dynamic model accounts for changes in energy requirements as body weight changes. It is an alternative for planning behavior-based scenarios, not a substitute for medication trial evidence.

Best for: Adults exploring the relationship between a weight goal, energy intake, physical activity, and maintenance.

Where the NIDDK Body Weight Planner shines

• It connects a weight goal with changes in intake and activity.
• It distinguishes reaching a goal from maintaining it.
• Its dynamic approach avoids treating weight change as a fixed, unchanging calorie-to-weight conversion.

The underlying modeling research describes the relationship between energy imbalance and body-weight change. Source: Hall et al., The Lancet, 2011; PMID 21872751. This is energy-balance modeling research, not a GLP-1 treatment trial.

Where the NIDDK Body Weight Planner falls short

• An energy-balance scenario is not a medication-specific response forecast.
• Entering an intended calorie intake does not establish that you will sustain it.
• A model does not decide whether a weight goal or dietary approach is medically appropriate.

For a 2026 comparison, use the NIDDK Body Weight Planner when the decision concerns intake and activity. Use medication trial evidence when the decision concerns treatment expectations. Do not interpret agreement between calculators as proof that either predicts your personal outcome.

Head-to-head with Fat Scientist

Dimension	NIDDK Body Weight Planner	What to compare in Fat Scientist
Main question	How intake and activity relate to weight change	Which inputs drive your current result?
Modeling approach	Dynamic energy balance	Does the calculation account for changing energy requirements?
Planning scope	Reaching and maintaining a goal	Does the result distinguish loss from maintenance?
Clinical role	Planning aid	Does the explanation keep planning separate from treatment advice?

Verdict: Use the NIDDK Body Weight Planner for calorie-and-activity scenarios; skip it as a replacement for a GLP-1-specific projection.

3. CDC Adult BMI Calculator: best for weight-status screening

The CDC Adult BMI Calculator calculates body mass index using height and weight. BMI is a screening measure, not a forecast. Choose it when you need to understand a current weight-status measure rather than estimate a future treatment trajectory.

Best for: Checking adult BMI as one part of a broader health discussion.

Where the CDC Adult BMI Calculator shines

• It answers a narrow, clearly defined question using height and weight.
• It provides a standardized measure that you can discuss with a healthcare provider.
• It does not require interpreting a projected weight-loss curve.

Where the CDC Adult BMI Calculator falls short

• BMI does not distinguish fat mass from lean mass.
• BMI alone does not describe your complete health status.
• A BMI calculation does not predict response to semaglutide, tirzepatide, or another treatment.

Dimension	CDC Adult BMI Calculator	What to compare in Fat Scientist
Output	Current BMI	Is the current output a screening measure or a forecast?
Inputs	Height and weight	Which additional assumptions affect the result?
Time horizon	Present status	Are you trying to describe today or estimate later?

Verdict: Use the CDC Adult BMI Calculator for screening; skip it when you need a weight-loss projection.

How to compare calculator results without mixing purposes

Before replacing Fat Scientist in 2026, identify the question you want answered. Then check whether the calculator's evidence, study population, and endpoint match that question. Keep interpretation separate from the numerical result.

Use this sequence:

• Define purpose: Decide whether you need a medication projection, an intake-and-activity scenario, or a screening measure.
• Check evidence: Identify the named trial or model behind the calculation.
• Match population: Compare the study population with your circumstances, including diabetes status.
• Check endpoint: Distinguish a trial endpoint from a modeled weekly trajectory.
• Discuss interpretation: Take the assumptions and result to your healthcare provider.

SELECT illustrates why endpoint selection matters. It studied cardiovascular outcomes with semaglutide in adults with established cardiovascular disease and overweight or obesity, without diabetes. Its primary question was cardiovascular benefit, not the accuracy of an individual's weekly weight forecast. Source: Lincoff et al., New England Journal of Medicine, 2023; PMID 37952131.

A calculator citing SELECT still needs an explanation of how that evidence relates to its particular output. A recognizable trial name is not enough; the endpoint must support the claim being made.

Why switch from Fat Scientist?

Switch when another calculator answers your question more directly, not because it produces a more appealing number. The decision should follow the task.

• You need medication-specific context: Choose a GLP-1 projection tool and examine the supporting trial population and duration.
• You need an intake-and-activity scenario: Choose the NIDDK Body Weight Planner and review the assumptions you enter.
• You need a present-day screening measure: Choose the CDC Adult BMI Calculator rather than a future-weight forecast.
• You need a treatment decision: Move beyond calculators and speak with your healthcare provider.

These are reasons to change calculation methods, not claims that Fat Scientist has a particular defect. A useful comparison evaluates the result you need and the evidence supporting it.

When staying with Fat Scientist is the right call

Stay with Fat Scientist if its calculation answers your question and you understand its assumptions. Switching tools does not itself improve the evidence or make an estimate personal.

For your 2026 comparison, retain the same starting information when comparing equivalent calculations. If the outputs disagree, inspect the model, population, and time horizon before selecting a preferred result. Do not choose a calculator simply because it forecasts greater weight loss.

FAQ

One last thing

A weekly graph can look more certain than the evidence behind it. STEP-1's 68-week result and SURMOUNT-1's 72-week result are study endpoints; neither turns a projected weekly curve into a personal promise.

Before acting on any calculator result, write down the source trial, study population, and endpoint. Those details make a more useful clinical conversation than a projected goal date alone. Individual results vary.

Related guides

• Online weight-loss calculators compared
• Average Ozempic weight-loss results by month
• Protein calculators for GLP-1 diets
• Semaglutide dosing calculators compared